CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-23 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +7,442,421 | 7,442,421 | ||
| 2020-10-13 | Green John L. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +695,700 | 695,700 | ||
| 2020-10-01 | Ferrante Karen Jean Director | Grant or award · Stock Option (Right to Buy) | +8,878 | $1.35 | $12K | 8,878 |
| 2020-10-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +9,247 | $1.35 | $13K | 9,247 |
| 2020-08-27 | Harwin Peter Evan Director | Grant or award · Director Stock Option (Right to Buy) | +28,661 | 28,661 | ||
| 2020-08-27 | CAIN CHRISTOPHER W. Director | Grant or award · Director Stock Option (Right to Buy) | +28,661 | 28,661 | ||
| 2020-08-18 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +101,000 | $2.62 | $265K | 4,355,273 |
| 2020-08-17 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +250,000 | $2.57 | $643K | 4,254,273 |
| 2020-08-14 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Purchase | +100,000 | $2.30 | $230K | 4,004,273 |
| 2020-07-09 | Fairmount Funds Management LLC 10% owner | Purchase · Series A Convertible Preferred Stock | +3,692 | $880.00 | $3.2M | 11,914 |
| 2020-07-09 | Fairmount Funds Management LLC 10% owner | Purchase · Series A Convertible Preferred Stock | +19,035 | $880.00 | $16.8M | 55,500 |
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition | +1,147,406 | 1,147,406 | ||
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition | +5,088,497 | 5,088,497 | ||
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition · Series A Convertible Preferred Stock | +8,222 | 8,222 | ||
| 2020-07-06 | Fairmount Funds Management LLC 10% owner | Other acquisition · Series A Convertible Preferred Stock | +36,465 | 36,465 | ||
| 2020-07-06 | Green John L. Chief Financial Officer | Option exercise | +109,459 | 109,459 | ||
| 2020-07-06 | Green John L. Chief Financial Officer | Shares withheld for taxes | −31,873 | $2.20 | $70K | 77,586 |
| 2020-07-06 | Green John L. Chief Financial Officer | Option exercise · Restricted Stock Units | −109,459 | 0 | ||
| 2020-07-01 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +61,338 | $0.31 | $19K | 61,338 |
| 2020-07-01 | Ros Matthew Director | Grant or award · Stock Option (Right to Buy) | +35,280 | $0.31 | $11K | 35,280 |
Page 9 of 14 · 268 trades